DR3 Regulates Negative Selection during Thymocyte Development

Author:

Wang Eddie C. Y.1,Thern Anette1,Denzel Angela1,Kitson Jeremy2,Farrow Stuart N.2,Owen Michael J.1

Affiliation:

1. Imperial Cancer Research Fund, Lincoln's Inn Fields, London WC2A 3PX, 1 and

2. Glaxo Wellcome, Stevenage, Herts SG1 2NY, 2 United Kingdom

Abstract

ABSTRACT DR3 (Ws1, Apo3, LARD, TRAMP, TNFSFR12) is a member of the death domain-containing tumor necrosis factor receptor (TNFR) superfamily, members of which mediate a variety of developmental events including the regulation of cell proliferation, differentiation, and apoptosis. We have investigated the in vivo role(s) of DR3 by generating mice congenitally deficient in the expression of the DR3 gene. We show that negative selection and anti-CD3-induced apoptosis are significantly impaired in DR3-null mice. In contrast, both superantigen-induced negative selection and positive selection are normal. The pre-T-cell receptor-mediated checkpoint, which is dependent on TNFR signaling, is also unaffected in DR3-deficient mice. These data reveal a nonredundant in vivo role for this TNF receptor family member in the removal of self-reactive T cells in the thymus.

Publisher

American Society for Microbiology

Subject

Cell Biology,Molecular Biology

Reference56 articles.

1. Acha-Orbea H. Superantigens and tolerance T cell receptors. Bell J. I. Owen M. I. Simpson E. 1995 224 265 Oxford University Press Oxford United Kingdom

2. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice;Amakawa R.;Cell,1996

3. Modulation of life and death by the TNF receptor superfamily;Baker S. J.;Oncogene,1998

4. Crystal structure of the soluble human 55 kD TNF receptor-human TNF beta complex: implications for TNF receptor activation;Banner D. W.;Cell,1993

5. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95);Bodmer J.-L.;Immunity,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3